odiparcil,
Odiparcil,
137215-12-4,
UNII-FIK1414ZI8,
FIK1414ZI8,
GSK 424323,
Odiparcil [INN],
AC1L50MX,
DSSTox_CID_31428,
DSSTox_RID_97314,
DSSTox_GSID_57639,
AC1Q6A07,
SCHEMBL4515803,
CHEMBL2107763,
DTXSID4057639,
JRHNIQQUVJOPQC-AQNFWKISSA-N,
4-methyl-2-oxo-2h-chromen-7-yl 5-thio-|A-d-xylopyranoside,
Tox21_113853,
ZINC31597280,
API0014045,
GSK-424323,
NCGC00253734-01,
SB 424323,
CAS-137215-12-4,
4-Methyl-7-(5-thio-beta-D-xylopyranosyloxy)-2H-chromen-2-one,
4-methyl-2-oxo-2H-1-benzopyran-7-yl 5-thio-beta-D-xylopyranoside,
2H-1-Benzopyran-2-one, 4-methyl-7-[(5-thio-beta-D-xylopyranosyl)oxy]-,
4-methyl-7-[(2R,3R,4S,5S)-3,4,5-trihydroxythian-2-yl]oxychromen-2-one,
7-((2R,3R,4S,5S)-tetrahydro-3,4,5-trihydroxy-2H-thiopyran-2-yloxy)-4-methyl-2H-chromen-2-one,
D0N6EA,
AR-1G3392,
CID216385,
SB-424323,
4-methyl-7-[(5-thio-beta-D-xylopyranosyl)oxy]-2H-1-benzopyran-2-one,
15900-38-6,